Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Mb, Vidriales"'
Autor:
M Torrebadell-Burriel, Manel Juan, MB Vidriales-Vicente, Heleia Roca-Ho, Clara Bueno, Pablo Menendez, Oscar Molina, Samanta Romina Zanetti, Paolo Petazzi, R Torres, T Velazco-Hernandez, Diego Sánchez-Martínez, O Hrusak, José Luis Fuster, Francisco Gutierrez-Agüera
Publikováno v:
Klinische Pädiatrie.
Autor:
M Urashima, A Ogata, D Chauhan, M Hatziyanni, MB Vidriales, DA Dedera, RL Schlossman, KC Anderson
Publikováno v:
Blood. 87:1928-1938
Interleukin-6 (IL-6), a product of bone marrow stromal cells (BMSCs), is a growth factor for multiple myeloma (MM) cells. Transforming growth factor-beta1 (TGF-beta1) is also produced by BMSCs and can regulate IL- 6 secretion by several tissues, incl
Autor:
Urashima M, Atsushi Ogata, Chauhan D, Mb, Vidriales, Teoh G, Hoshi Y, Rl, Schlossman, Ja, Decaprio, Kc, Anderson
Publikováno v:
Europe PubMed Central
Interleukin-6 (IL-6) mediates autocrine and paracrine growth of multiple myeloma (MM) cells and inhibits tumor cell apoptosis. Abnormalities of retinoblastoma protein (pRB) and mutations of RB gene have been reported in up to 70% of MM patients and 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::40199cd947e02102d6d7a8afb8e63cca
http://europepmc.org/abstract/med/8822942
http://europepmc.org/abstract/med/8822942
Autor:
Ijurko C; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Plaza Doctores de la Reina, s/n, Salamanca, 37007, Spain.; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain., Romo-González M; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Plaza Doctores de la Reina, s/n, Salamanca, 37007, Spain.; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain.; Present Address: Susan Lehman Cullman Laboratory for Cancer Research, Rutgers University, Piscataway, NJ, 08854, USA., Prieto-Bermejo R; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Plaza Doctores de la Reina, s/n, Salamanca, 37007, Spain.; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain.; Present Address: Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ, 08901, USA., Díez-Campelo M; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain., Vidriales MB; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Muntión S; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Sánchez-Guijo F; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain., Sánchez-Yagüe J; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Plaza Doctores de la Reina, s/n, Salamanca, 37007, Spain.; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain., Hernández-Hernández Á; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Plaza Doctores de la Reina, s/n, Salamanca, 37007, Spain. angelhh@usal.es.; IBSAL (Instituto de Investigación Biomédica de Salamanca), Salamanca, 37007, Spain. angelhh@usal.es.
Publikováno v:
Biomarker research [Biomark Res] 2024 Oct 29; Vol. 12 (1), pp. 128. Date of Electronic Publication: 2024 Oct 29.
Autor:
Fernández-Sánchez A; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Hernández-Sánchez A; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., De Ramón C; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Chillón MC; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Vidriales MB; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Baile-González M; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Fuentes-Morales CT; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Sierra-Pacho M; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., López-Corral L; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain., Sánchez-Guijo F; Hematology Department, IBSAL-University Hospital of Salamanca, Department of Medicine and Cancer Research Center (CIC), University of Salamanca, 37007 Salamanca, Spain.
Publikováno v:
Biomedicines [Biomedicines] 2024 Oct 15; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 15.
Autor:
Labrador J; Hospital Universitario de Burgos, Burgos, Spain., Martínez-Cuadrón D; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Boluda B; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Serrano J; Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain., Gil C; Hospital General Universitario de Alicante, Alicante, Spain., Pérez-Simón JA; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Sevilla, Spain., Bernal T; Hospital Universitario Central Asturias, ISPA, IUOPA, Oviedo, Spain., Bergua JM; Hospital San Pedro de Alcántara, Cáceres, Spain., Martínez-López J; Hospital Universitario 12 de Octubre, Complutense University, i+12, CNIO, Madrid, Spain., Rodríguez-Medina C; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Vidriales MB; Hospital Universitario de Salamanca, Salamanca, Spain., García-Boyero R; Hospital General Universitario de Castellón, Castellón de la Plana, Spain., Algarra L; Hospital General Universitario de Albacete, Albacete, Spain., Polo M; Hospital Clínico San Carlos, Madrid, Spain., Sayas MJ; Hospital Universitario Doctor Peset, Valencia, Spain., Tormo M; Hospital Clínico Universitario de Valencia, Valencia, Spain., Alonso-Domínguez JM; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Herrera P; Hospital Universitario Ramón y Cajal, Madrid, Spain., Lavilla E; Hospital Universitario Lucus Augusti, Lugo, Spain., Ramos F; Hospital Universitario de León, León, Spain., Amigo ML; Hospital General Universitario Morales Meseguer, Murcia, Spain., Vives-Polo S; Hospital Germans Trias i Pujol-ICO, Badalona, Spain., Rodríguez-Macías G; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Mena-Durán A; Hospital General de Valencia, Valencia, Spain., Pérez-Encinas MM; Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Arce-Fernández O; Hospital de Basurto, Bilbao, Spain., Cuello R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Sánchez-García J; Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain., Gómez-Casares MT; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Chillón MC; Hospital Universitario de Salamanca, Salamanca, Spain., Calasanz MJ; CIMA Lab Diagnostics. Universidad de Navarra, Pamplona, Spain., Ayala R; Hospital Universitario 12 de Octubre, Complutense University, i+12, CNIO, Madrid, Spain., Rodriguez-Veiga R; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Barragán E; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Montesinos P; Hospital Universitari I Politécnic La Fe, Valencia, Spain.
Publikováno v:
Cancer [Cancer] 2024 Oct 15; Vol. 130 (20), pp. 3436-3451. Date of Electronic Publication: 2024 Jun 19.
Autor:
Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., González-Barca E; Department of Hematology, Instititut Catala D'Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Ferrà C; Department of Hematology, Instititut Catala D'Oncologia, Hospital Germans Trias i Pujol, Universitat de Vic/Universitat Central de Catalunya, Barcelona, Spain., Ríos-Herranz E; Department of Hematology, Hospital Nuestra Señora de Valme, Sevilla, Spain., Fernández de la Mata M; Department of Hematology, Hospital Universitario Reina Sofía, Córdoba, Spain., Delgado J; Department of Hematology, Hospital Clínic, Barcelona, Spain., Andreu R; Department of Hematology, Hospital Universitario La Fe, Valencia, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain., Terol MJ; Department of Hematology, Hospital Clínico Universitario de Valencia, Valencia, Spain., Navarro A; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, CIC- IBMCC (USAL-CSIC) CIBERONC, Salamanca, Spain., Vidriales MB; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, CIC- IBMCC (USAL-CSIC) CIBERONC, Salamanca, Spain., Baltasar P; Department of Hematology, Hospital Universitario La Paz, Madrid, Spain., De la Serna J; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Ramírez Á; Department of Hematology, Hospital Universtiario Central de Asturias, Oviedo, Spain., Ballester C; Department of Hematology, Hospital Universitari Son Espases, Palma, Spain., Moreno C; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., García-Marco JA; Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Córdoba R; Department of Hematology, Fundación Jiménez Díaz, Madrid, Spain., Yáñez L; Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Casado LF; Department of Hematology, Hospital General Universitario de Toledo, Toledo, Spain., González M; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, CIC- IBMCC (USAL-CSIC) CIBERONC, Salamanca, Spain., Bosch F; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2024 May 25; Vol. 73, pp. 102642. Date of Electronic Publication: 2024 May 25 (Print Publication: 2024).
Autor:
Martín-Martín L; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain., Gutiérrez-Herrero S; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Herrero-García M; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Martín García-Sancho A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Yeguas A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-López AÁ; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., López-Corral L; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pérez-López E; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., García-Blázquez M; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Sánchez-Guijo F; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Vidriales MB; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Gaipa G; Tettamanti Center and Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain. orfao@usal.es.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain. orfao@usal.es.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. orfao@usal.es.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain. orfao@usal.es.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain. orfao@usal.es.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 May 17; Vol. 14 (1), pp. 83. Date of Electronic Publication: 2024 May 17.
Autor:
Martínez-Cuadrón D; Hospital Universitari i Politècnic La Fe, Valencia, Spain; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid. martinez_davcua@gva.es., Megías-Vericat JE; Servicio de Farmacia, Área del Medicamento. Hospital Universitari i Politècnic La Fe, Valencia., Gil C; Hospital General Universitario de Alicante, Alicante., Bernal T; Hospital Universitario Central de Asturias, Asturias, Instituto Universitario de Oncología del Principado de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, ISPA., Tormo M; Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia., Martínez-Sánchez P; Hospital Universitario 12 de Octubre, Madrid., Rodríguez-Medina C; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas., Serrano J; Hospital Universitario Reina Sofía-IMIBIC, Córdoba., Herrera P; Hospital Universitario Ramón y Cajal, Madrid., Simón JAP; Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CISC), Universidad de Sevilla, Sevilla., Sayas MJ; Hospital Universitario Doctor Peset, Valencia., Bergua J; Hospital San Pedro Alcántara, Cáceres., Lavilla-Rubira E; Hospital Universitario Lucus Augusti, Lugo., Amigo ML; Hospital General Universitario Morales Meseguer, Murcia., Benavente C; Hospital Clínico San Carlos, Madrid., Lorenzo JLL; Hospital Universitario Fundación Jiménez Díaz, Madrid., Pérez-Encinas MM; Hospital Clínico Universitario de Santiago, Santiago de Compostela., Vidriales MB; Hospital Clínico Universitario de Salamanca, Salamanca., Colorado M; Hospital Universitario Marqués de Valdecilla, Santander., De Rueda B; Hospital Universitario Miguel Servet, Zaragoza., García-Boyero R; Hospital General Universitari de Castelló, Castellón., Marini S; Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra., García-Suárez J; Hospital Universitario Príncipe de Asturias, Madrid., López-Pavía M; Hospital General Universitario de Valencia, Valencia., Gómez-Roncero MI; Hospital Universitario de Toledo, Toledo., Noriega V; Complejo Hospitalario Universitario A Coruña, A Coruña., López A; Hospital Arnau de Vilanova, Valencia., Labrador J; Hospital Universitario de Burgos, Burgos., Cabello A; Hospital Universitario Nuestra Señora de Candelaria, Tenerife., Sossa C; FOSCAL, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga., Algarra L; Hospital General Universitario de Albacete, Albacete., Stevenazzi M; Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay., Solana-Altabella A; Servicio de Farmacia, Área del Medicamento. Hospital Universitari i Politècnic La Fe, Valencia., Boluda B; Hospital Universitari i Politècnic La Fe, Valencia, Spain; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia., Montesinos P; Hospital Universitari i Politècnic La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid.
Publikováno v:
Haematologica [Haematologica] 2024 Jan 01; Vol. 109 (1), pp. 115-128. Date of Electronic Publication: 2024 Jan 01.
Autor:
García-Álvarez M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Yeguas A; Hematology Department, Complejo Asistencial Universitario de Palencia, 34005 Palencia, Spain., Jiménez C; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Medina-Herrera A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., González-Calle V; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Hernández-Ruano M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Maldonado R; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Aires I; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Casquero C; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Sánchez-Villares I; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Balanzategui A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Sarasquete ME; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Alcoceba M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Vidriales MB; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., González-Díaz M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., García-Sanz R; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Chillón MC; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Publikováno v:
Biomedicines [Biomedicines] 2023 Dec 27; Vol. 12 (1). Date of Electronic Publication: 2023 Dec 27.